miR-3940-5p reduces amyloid β production via selectively targeting PSEN1

Yanmei Qi1, Xu Wang1,2, Xihan Guo1

  • 1School of Life Sciences, The Engineering Research Center of Sustainable Development and Utilization of Biomass Energy, Yunnan Normal University, Kunming, Yunnan, China.

PubMed

Insights

This study identifies miR-3940-5p as a microRNA that directly targets presenilin1 (PSEN1) in Alzheimer's disease (AD). Its overexpression reduces PSEN1 and amyloid-beta (Aβ) production, offering a potential therapeutic target for AD.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ) accumulation.
  • MicroRNAs (miRNAs) play a role in AD pathogenesis.
  • miRNAs directly targeting presenilin1 (PSEN1), crucial for Aβ production, are understudied.

Purpose of the Study:

  • To identify miRNAs targeting PSEN1.
  • To investigate the effect of identified miRNAs on Aβ production.

Main Methods:

  • Bioinformatic prediction of miRNAs targeting PSEN1.
  • Dual-luciferase reporter assays to validate targeting specificity.
  • Cell culture experiments (SH-SY5Y cells) with miRNA mimics/inhibitors, RT-qPCR, Western Blot, and ELISA to assess PSEN1 and Aβ levels.

Main Results:

  • miR-3940-5p was validated as a direct target of PSEN1.
  • Overexpression of miR-3940-5p reduced PSEN1 mRNA and protein levels.
  • miR-3940-5p mimics significantly decreased Aβ42 and Aβ40 production in SH-SY5Y-APPswe cells.

Conclusions:

  • miR-3940-5p antagonizes Aβ production by directly targeting PSEN1.
  • This finding highlights miR-3940-5p as a potential therapeutic target for Alzheimer's disease.